scholarly article | Q13442814 |
P2093 | author name string | Diana Ross | |
Lakshmanan Krishnamurti | |||
Nitya Bakshi | |||
Cynthia B Sinha | |||
P2860 | cites work | Federal Response to the Opioid Crisis | Q64137198 |
The number of people with sickle-cell disease in the United States: national and state estimates | Q82320507 | ||
Race and social attitudes about sickle cell disease | Q84611859 | ||
An experimental method for assessing whether marijuana use reduces opioid use in patients with chronic pain | Q89037495 | ||
Marijuana Use in Adults Living with Sickle Cell Disease | Q90263166 | ||
Association of Chronic Opioid Use With Presidential Voting Patterns in US Counties in 2016 | Q91057249 | ||
Marijuana for Glaucoma: A Recipe for Disaster or Treatment? | Q26785465 | ||
Adult sickle cell quality-of-life measurement information system (ASCQ-Me): conceptual model based on review of the literature and formative research | Q27318644 | ||
Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups | Q29618084 | ||
A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution | Q34155329 | ||
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review | Q34481944 | ||
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. | Q34518212 | ||
Problematic hospital experiences among adult patients with sickle cell disease | Q35619548 | ||
The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization | Q37438029 | ||
A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease | Q37622209 | ||
Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study | Q38088331 | ||
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial | Q40151883 | ||
The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association | Q42109748 | ||
Racial disparities in the monitoring of patients on chronic opioid therapy | Q43567482 | ||
How to parse the protective, the punitive and the prejudicial in chronic opioid therapy? | Q44337315 | ||
Treating pain in sickle cell disease with opioids: clinical advances, ethical pitfalls | Q48070421 | ||
Medical Marijuana: Is the Cart Before the Horse? | Q48114032 | ||
Early Results of a Pragmatic Trial: Report to a State Agency on Acupuncture for the Underserved Amid the Opioid Crisis | Q49952279 | ||
Physicians' attitude and practices in sickle cell disease pain management. | Q50946123 | ||
Sickle cell-related pain: perceptions of medical practitioners. | Q52275377 | ||
Nurses' attitudes and practices in sickle cell pain management. | Q52280388 | ||
Mortality in sickle cell disease. Life expectancy and risk factors for early death. | Q55065788 | ||
Clinical Policy: Critical Issues in the Prescribing of Opioids for Adult Patients in the Emergency Department | Q57695018 | ||
Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers | Q64132480 | ||
Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline | Q64136510 | ||
P433 | issue | 5 | |
P921 | main subject | chronic pain | Q1088113 |
P304 | page(s) | e194410 | |
P577 | publication date | 2019-05-03 | |
P1433 | published in | JAMA Network Open | Q63615743 |
P1476 | title | Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study | |
P478 | volume | 2 |